| Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results SE Plon, DM Eccles, D Easton, WD Foulkes, M Genuardi, MS Greenblatt, ... Human mutation 29 (11), 1282-1291, 2008 | 1000 | 2008 |
| Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 MJL Ligtenberg, RP Kuiper, TL Chan, M Goossens, KM Hebeda, ... Nature genetics 41 (1), 112-117, 2009 | 899 | 2009 |
| A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome HC Van Santvoort, OJ Bakker, TL Bollen, MG Besselink, UA Ali, ... Gastroenterology 141 (4), 1254-1263, 2011 | 884 | 2011 |
| Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ... Journal of medical genetics 52 (6), 361-374, 2015 | 634 | 2015 |
| Deficient mismatch repair system in patients with sporadic advanced colorectal cancer M Koopman, GAM Kortman, L Mekenkamp, MJL Ligtenberg, ... British journal of cancer 100 (2), 266-273, 2009 | 554 | 2009 |
| Cancer risks in BRCA2 families: estimates for sites other than breast and ovary CJ Van Asperen, RM Brohet, EJ Meijers-Heijboer, N Hoogerbrugge, ... Journal of medical genetics 42 (9), 711-719, 2005 | 508 | 2005 |
| A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general … AC Antoniou, X Wang, ZS Fredericksen, L McGuffog, R Tarrell, ... Nature genetics 42 (10), 885-892, 2010 | 406 | 2010 |
| The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition A Binnerts, GR Swart, JHP Wilson, N Hoogerbrugge, HAP Pois, ... Clinical endocrinology 37 (1), 79-87, 1992 | 403 | 1992 |
| A germline homozygous mutation in the base-excision repair gene NTHL1 causes adenomatous polyposis and colorectal cancer RDA Weren, MJL Ligtenberg, CM Kets, RM De Voer, ETP Verwiel, ... Nature genetics 47 (6), 668-671, 2015 | 392 | 2015 |
| TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes MWG Ruijs, S Verhoef, MA Rookus, R Pruntel, AH van der Hout, ... Journal of medical genetics 47 (6), 421-428, 2010 | 360 | 2010 |
| Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors AR Mensenkamp, IP Vogelaar, WAG van Zelst–Stams, M Goossens, ... Gastroenterology 146 (3), 643-646. e8, 2014 | 352 | 2014 |
| Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study MJE Kempers, RP Kuiper, CW Ockeloen, PO Chappuis, P Hutter, ... The lancet oncology 12 (1), 49-55, 2011 | 343 | 2011 |
| Risks of less common cancers in proven mutation carriers with lynch syndrome C Engel, M Loeffler, V Steinke, N Rahner, E Holinski-Feder, W Dietmaier, ... Journal of Clinical Oncology 30 (35), 4409-4415, 2012 | 342 | 2012 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 306 | 2015 |
| Hereditary diffuse gastric cancer: updated clinical practice guidelines VR Blair, M McLeod, F Carneiro, DG Coit, JL D'Addario, JM van Dieren, ... The Lancet Oncology 21 (8), e386-e397, 2020 | 303 | 2020 |
| Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction AC Antoniou, J Beesley, L McGuffog, OM Sinilnikova, S Healey, ... Cancer research 70 (23), 9742-9754, 2010 | 255 | 2010 |
| Hyperglycemia in the acute phase of stroke is not caused by stress. F Van Kooten, N Hoogerbrugge, P Naarding, PJ Koudstaal Stroke 24 (8), 1129-1132, 1993 | 230 | 1993 |
| BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. AJ Rijnsburger, IM Obdeijn, R Kaas, MM Tilanus-Linthorst, C Boetes, ... | 229 | 2010 |
| Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers RS Van der Post, LA Kiemeney, MJL Ligtenberg, JA Witjes, ... Journal of medical genetics 47 (7), 464-470, 2010 | 224 | 2010 |
| Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk SW Ten Broeke, RM Brohet, CM Tops, HM van der Klift, ME Velthuizen, ... J Clin Oncol 33 (4), 319-325, 2015 | 223 | 2015 |
